{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:24:28Z","timestamp":1791321868167,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1992,5,1]],"date-time":"1992-05-01T00:00:00Z","timestamp":704678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"vor","delay-in-days":9021,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1992,5]]},"DOI":"10.1111\/1523-1747.ep12499907","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T14:41:41Z","timestamp":1089902501000},"page":"686-692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"title":["Extracorporeal Photochemotherapy Induces the Production of Tumor Necrosis Factor-\u03b1 by Monocytes: Implications for the Treatment of Cutaneous T-Cell Lymphoma and Systemic Sclerosis"],"prefix":"10.1016","volume":"98","author":[{"given":"Benjamin R","family":"Vowels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Cassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret H","family":"Boufal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence J","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12499907_bb0010","first-page":"662","article-title":"Specific vaccination against photoinactivated cloned T cells (abstract)","volume":"36","author":"Khavari","year":"1988","journal-title":"Clin Res"},{"key":"10.1111\/1523-1747.ep12499907_bb0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0022-202X(89)90180-2","article-title":"Specific suppression of antiallograft immunity by immunization with syngeneic photoinactivated effector lymphocytes","volume":"92","author":"Perez","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12499907_bb0020","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.134.3.1644","article-title":"Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulared cytolytic T lymphocyte precursors","volume":"134","author":"Erard","year":"1985","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0025","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1096\/fasebj.4.11.2199284","article-title":"Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF)","volume":"4","author":"Akira","year":"1990","journal-title":"Faseb J"},{"key":"10.1111\/1523-1747.ep12499907_bb0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4049\/jimmunol.130.2.763","article-title":"Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL-2","volume":"130","author":"Finke","year":"1983","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0035","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.144.12.4555","article-title":"Evidence for tumor necrosis factor-\u03b1 involvement in the optimal induction of class I allospecific cytotoxic T cells","volume":"144","author":"Robinet","year":"1990","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0040","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.4049\/jimmunol.138.8.2711","article-title":"Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells","volume":"138","author":"Ruggiero","year":"1987","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0045","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI114866","article-title":"Tumor necrosis factor-\u03b2 and interferon-\u03b3 suppress the activation of human type 1 collagen gene expression by transforming growth factor-\u03b2","volume":"86","author":"Kahari","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1111\/1523-1747.ep12499907_bb0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0022-202X(89)90185-1","article-title":"Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta","volume":"92","author":"Duncan","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12499907_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: Preliminary results","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12499907_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.1992.01680130051005","article-title":"Treatment of systemic sclerosis with extracorporeal photochemotherapy: Results of a multicenter trial","volume":"128","author":"Rook","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12499907_bb0065","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/archderm.1991.01680090099012","article-title":"Combined therapy of the S\u00e9zary syndrome with extracorporeal photochemotherapy and low dose interferon alpha: clinical, molecular, and immunologic observations","volume":"127","author":"Rook","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12499907_bb0070","first-page":"45","article-title":"Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities","volume":"35","author":"Grunfeld","year":"1990","journal-title":"Adv Int Med"},{"key":"10.1111\/1523-1747.ep12499907_bb0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.2413547","article-title":"Tumor necrosis factor (TNF)","volume":"230","author":"Old","year":"1985","journal-title":"Science"},{"key":"10.1111\/1523-1747.ep12499907_bb0080","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.1697984","article-title":"LFA-3, CD44, and CD45: Physiological triggers of human monocyte TNF and IL-1 release","volume":"249","author":"Webb","year":"1990","journal-title":"Science"},{"key":"10.1111\/1523-1747.ep12499907_bb0085","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.4049\/jimmunol.144.9.3643","article-title":"IFN-\u03b1 and IFN-\u03b3 can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity","volume":"144","author":"Webb","year":"1990","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0090","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/1097-0142(197602)37:2<714::AID-CNCR2820370216>3.0.CO;2-Q","article-title":"T and B cells and cell mediated immunity in mycosis fungoides","volume":"37","author":"Nordquist","year":"1976","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12499907_bb0095","first-page":"209","article-title":"Recent advances in the cutaneous T cell lymphomas","volume":"64","author":"Edelson","year":"1977","journal-title":"Bull Cancer"},{"key":"10.1111\/1523-1747.ep12499907_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM198301133080214","article-title":"Decreased natural killer cell activity in cutaneous T cell lymphomas","volume":"308","author":"LaRoche","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12499907_bb0105","first-page":"5604","article-title":"Clinical trials with human tumor necrosis factor: In vivo and in vitro effects on human mononuclear phagocyte function","volume":"48","author":"Conkling","year":"1988","journal-title":"Cancer Res"},{"key":"10.1111\/1523-1747.ep12499907_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/323086a0","article-title":"Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon, and interleukin-1","volume":"323","author":"Philip","year":"1986","journal-title":"Nature"},{"key":"10.1111\/1523-1747.ep12499907_bb0115","first-page":"788","article-title":"Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine activated killer cell cytotoxicity","volume":"48","author":"Owen-Schaub","year":"1988","journal-title":"Cancer Res"},{"key":"10.1111\/1523-1747.ep12499907_bb0120","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.4049\/jimmunol.138.12.4185","article-title":"Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells","volume":"138","author":"Ostensen","year":"1987","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.3933111","article-title":"Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro","volume":"230","author":"Sugarman","year":"1985","journal-title":"Science"},{"key":"10.1111\/1523-1747.ep12499907_bb0130","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4049\/jimmunol.136.7.2445","article-title":"Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma","volume":"136","author":"Ruggiero","year":"1986","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0135","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4049\/jimmunol.138.6.1786","article-title":"Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses","volume":"138","author":"Scheurich","year":"1987","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0171-2985(88)80087-1","article-title":"Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability","volume":"177","author":"Holtlmann","year":"1988","journal-title":"Immunobiol"},{"key":"10.1111\/1523-1747.ep12499907_bb0145","first-page":"24","article-title":"Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-y","volume":"7","author":"Watanabe","year":"1988","journal-title":"J Biol Res Mod"},{"key":"10.1111\/1523-1747.ep12499907_bb0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0277-5379(86)90107-0","article-title":"Recombinant tumor necrosis factor: its effect and its synergisra with interferon-\u03b3 on a variety of normal and transformed human cell lines","volume":"22","author":"Fransen","year":"1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1111\/1523-1747.ep12499907_bb0155","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/j.2326-5205.1989.tb00012.x","article-title":"A strategy for determining the pathogenesis of systemic sclerosis Is transforming growth factor \u03b2 the answer?","volume":"32","author":"LeRoy","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1523-1747.ep12499907_bb0160","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1172\/JCI114793","article-title":"Co-localization of transforming growth factor \u03b22 with \u03b1- (I)procollagen mRNA in tissue sections of patients with systemic sclerosis","volume":"86","author":"Kulozik","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1111\/1523-1747.ep12499907_bb0165","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.162.6.2163","article-title":"Cachetin\/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts","volume":"162","author":"Dayer","year":"1985","journal-title":"J Exp Med"},{"key":"10.1111\/1523-1747.ep12499907_bb0170","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/1523-1747.ep12876280","article-title":"Tumor necrosis factor a induces invasiveness of human skin fibroblasts in vitro","volume":"94","author":"Schirren","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12499907_bb0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI112350","article-title":"Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells","volume":"77","author":"Dayer","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1111\/1523-1747.ep12499907_bb0180","first-page":"5868","article-title":"Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and \u03b3-interferon","volume":"47","author":"Hori","year":"1987","journal-title":"Cancer Res"},{"key":"10.1111\/1523-1747.ep12499907_bb0185","first-page":"384","article-title":"Human recombinant alpha- and gamma-interferons enhance the cytotoxic properties of tumor necrosis factor on human melanoma","volume":"7","author":"Bregman","year":"1988","journal-title":"J Biol Res Mod"},{"key":"10.1111\/1523-1747.ep12499907_bb0190","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.1989.03420150067039","article-title":"Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule-1 (ICAM-1) in Sezary syndrome","volume":"261","author":"Nickoloff","year":"1989","journal-title":"JAMA"},{"key":"10.1111\/1523-1747.ep12499907_bb0195","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.4049\/jimmunol.135.6.3972","article-title":"Cachectin\/tumor necrosis factor production, distribution, and metabolic fate in vivo","volume":"135","author":"Beutler","year":"1985","journal-title":"J Immunol"},{"key":"10.1111\/1523-1747.ep12499907_bb0200","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM199006073222302","article-title":"Activation of coagulation after administration of tumor necrosis factor to normal subjects","volume":"322","author":"Van der Poll","year":"1990","journal-title":"N Eng J Med"},{"key":"10.1111\/1523-1747.ep12499907_bb0205","first-page":"25","article-title":"Photopheresis for T cell mediated diseases","author":"Heald","year":"1988","journal-title":"Advances in Dermatology"},{"key":"10.1111\/1523-1747.ep12499907_bb0210","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.163.6.1433","article-title":"Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1","volume":"163","author":"Dinarello","year":"1986","journal-title":"J Exp Med"},{"key":"10.1111\/1523-1747.ep12499907_bb0215","first-page":"393","article-title":"A double-blind clinical trial of extracorporeal photopheresis in chronic progressive multiple sclerosis","volume":"40","author":"Rostami","year":"1990","journal-title":"Neurology"},{"key":"10.1111\/1523-1747.ep12499907_bb0220","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/art.1780340604","article-title":"Treatment of rheumatoid arthritis by extracorporeal photochemotherapy: a pilot study","volume":"34","author":"Malawista","year":"1991","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9290140Y?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9290140Y?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:52:47Z","timestamp":1698731567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X9290140Y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["S0022202X9290140Y"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12499907","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1992,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracorporeal Photochemotherapy Induces the Production of Tumor Necrosis Factor-\u03b1 by Monocytes: Implications for the Treatment of Cutaneous T-Cell Lymphoma and Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1523-1747.ep12499907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1992 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}